iRhythm Technologies

Yahoo Finance • 5 days ago

Morgan Stanley Raises iRhythm (IRTC) PT on MedTech Recovery Outlook

iRhythm Technologies, Inc. (NASDAQ:IRTC) is one of the best healthcare AI stocks to buy now. On December 2, Morgan Stanley raised its price target on iRhythm Technologies, Inc. (NASDAQ:IRTC) from $195 to $205, while maintaining an Overweig... Full story

Yahoo Finance • 19 days ago

From Hype to P&L: Hospitals Now Buying AI That Pays

VANCOUVER, British Columbia, Dec. 08, 2025 (GLOBE NEWSWIRE) --  USANewsGroup.comNews Commentary – Hospitals running on thin margins are done chasing clinical moonshots[1]. They want AI that improves the bottom line. Healthcare AI spendin... Full story

Yahoo Finance • 24 days ago

Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary duties to share... Full story

Yahoo Finance • last month

New Data at the Asia Pacific Heart Rhythm Society (APHRS) 2025 Highlight the Performance of iRhythm’s Zio Long-Term Continuous Monitoring in an Asian Population

iRhythm Technologies presented new data during the joint Asia Pacific Heart Rhythm Society (APHRS) and Japan Heart Rhythm Society (JHRS) scientific sessions.Large-scale analysis of more than 400,000 patients1 supports the consistency and g... Full story

Yahoo Finance • last month

第18回アジア太平洋不整脈学会学術大会（APHRS2025）で発表された新たなデータにより　アジア人集団におけるiRhythm社のZio長期連続モニタリングの性能が明らかに

iRhythm Technologies, Inc.は、アジア太平洋不整脈学会学術大会（APHRS2025）と第71回日本不整脈心電学会学術大会（JHRS2025）の合同学術集会において新しいデータを発表しました。40万人を超える患者を対象とした大規模解析 1 により、長期間の心電図（ECG）モニタリングの性能の一貫性と一般化可能性が裏付けられました。アジア人患者（コホートの3.4%）における中央値の装着時間および解析可能時間は非アジア人患者と同等であり、この結果は既発表の... Full story

Yahoo Finance • 2 months ago

iRhythm Technologies to Participate in Upcoming Investor Conferences

SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its ma... Full story

Yahoo Finance • 2 months ago

Earnings To Watch: Masimo (MASI) Reports Q3 Results Tomorrow

Medical tech company Masimo (NASDAQ:MASI) will be reporting results this Tuesday after market hours. Here’s what you need to know. Masimo beat analysts’ revenue expectations by 0.6% last quarter, reporting revenues of $370.9 million, up 7... Full story

Yahoo Finance • 2 months ago

Closing Bell Movers: Amazon soars to all-time highs on earnings

In the opening hour of the evening session, U.S. equity futures are notably higher, with S&P 500 up 0.5% and Nasdaq 100 contracts up 1.0%.  In commodities, WTI Crude Oil is little changed just above $60 per barrel while precious metals are... Full story

Yahoo Finance • 2 months ago

IRhythm targets $735M–$740M 2025 revenue as free cash flow turns positive, driven by EHR integration and innovative channels

Earnings Call Insights: iRhythm Technologies, Inc. (IRTC) Q3 2025 MANAGEMENT VIEW * Quentin Blackford, President and CEO, opened the call by highlighting "another quarter of strong commercial momentum, reflecting our disciplined execut... Full story

Yahoo Finance • 2 months ago

iRhythm Technologies Announces Third Quarter 2025 Financial Results

SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial r... Full story

Yahoo Finance • 2 months ago

iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025

SAN FRANCISCO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it wil... Full story

Yahoo Finance • 3 months ago

iRhythm Technologies, Inc. (IRTC) Shares Surge 96% Despite FDA Warning and Legal Challenges

We recently compiled a list of the 12 Best Performing Healthcare Stocks to Buy Right Now.  iRhythm Technologies, Inc. is one of them. iRhythm Technologies, Inc. (NASDAQ:IRTC) is a digital healthcare leader specializing in device-based amb... Full story

Yahoo Finance • 3 months ago

CoreWeave upgraded, Lululemon downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Wells Fargo upgraded CoreWeave (CRWV)... Full story

Yahoo Finance • 3 months ago

IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. – IRTC

NEW YORK and NEW ORLEANS, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation in... Full story

Yahoo Finance • 4 months ago

IRTC Crosses Above Average Analyst Target

In recent trading, shares of iRhythm Technologies Inc (Symbol: IRTC) have crossed above the average analyst 12-month target price of $104.08, changing hands for $106.99/share. When a stock reaches the target an analyst has set, the analys... Full story

Yahoo Finance • 4 months ago

AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies’ Zio LTCM Service

Oxford University-led AMALFI clinical trial results presented at the European Society of Cardiology (ESC) Congress 2025 and published in the Journal of the American Medical Association (JAMA).AMALFI tested whether home-based, self-applied... Full story

Yahoo Finance • 4 months ago

Does New AVALON Study’s Results Strengthen the Bull Case for iRhythm Technologies (IRTC)?

iRhythm Technologies recently announced the publication of the AVALON study in the American Journal of Managed Care, which found that the Zio long-term continuous monitoring service led to faster cardiac arrhythmia diagnoses, fewer cardiov... Full story

Yahoo Finance • 4 months ago

BofA Securities initiates coverage on iRhythm Technologies stock with Buy rating

Investing.com - BofA Securities initiated coverage on iRhythm Technologies (NASDAQ:IRTC) with a Buy rating and set a price target of $200.00 on Wednesday. The stock, currently trading at $158.52, has delivered impressive returns with a 126... Full story

Yahoo Finance • 4 months ago

AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm’s Zio LTCM Clinical Superiority

In the largest real-world study of its kind with 428,707 patients, the Zio LTCM service outperformed other studied monitoring approaches in cardiac arrhythmia diagnostic yield, time to diagnosis, cardiovascular events, and total health car... Full story

Yahoo Finance • 5 months ago

iRhythm Technologies Inc (NASDAQ:IRTC) Fits Mark Minervini’s Trend-Following Strategy with Strong Technicals and Growth Momentum

iRhythm Technologies Inc (NASDAQ:IRTC [https://www.chartmill.com/stock/quote/IRTC]) has become a possible choice for investors using Mark Minervini’s trend-following method, which blends technical strength with fundamental growth trends. T... Full story